CAMBRIDGE, Mass., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Morgan Stanley Global Healthcare Conference. Marc Beer, CEO of Aegerion, is scheduled to present on Wednesday, September 11, 2013 at 1:30 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
